首页> 美国卫生研究院文献>other >HER-2eu Targeted Delivery of a Nanoprobe Enables Dual Photoacoustic and Fluorescence Tomography of Ovarian Cancer
【2h】

HER-2eu Targeted Delivery of a Nanoprobe Enables Dual Photoacoustic and Fluorescence Tomography of Ovarian Cancer

机译:HER-2 / neu纳米探针的靶向递送可实现卵巢癌的双光声和荧光层析成像。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Development of sensitive and specific imaging approaches for the detection of ovarian cancer holds great promise for improving survival of ovarian cancer patients. Here we describe a dual-modality photoacoustic and fluorescence molecular tomography (PAT/FMT) approach in combination with a targeted imaging probe for three-dimensional imaging of ovarian tumors in mice. We found that the selective accumulation of the HER-2eu targeted magnetic iron oxide nanoparticles (IONPs) led to about 5-fold contrast enhancements in the tumor for PAT, while near-infrared (NIR) dye labeled nanoparticles emitted strong optical signals for FMT. Both PAT and FMT were demonstrated to be able to detect ovarian tumors located deep in the peritoneal cavity in mice. The targeted nanoprobes allowed mapping tumors in high resolution via PAT, and with high sensitivity and specificity via FMT. This study demonstrated the potential of the application of HER-2eu-targeted PAT/FMT approach for non-invasive or intraoperative imaging of ovarian cancer.
机译:用于检测卵巢癌的灵敏且特异性的成像方法的发展对于改善卵巢癌患者的生存有着广阔的前景。在这里,我们描述了一种双模态光声和荧光分子层析成像(PAT / FMT)方法,结合靶向成像探针对小鼠卵巢肿瘤进行三维成像。我们发现HER-2 / neu靶向磁性氧化铁纳米粒子(IONPs)的选择性积累导致PAT肿瘤中的对比度增强了约5倍,而近红外(NIR)染料标记的纳米粒子则发出了较强的光信号。 FMT。事实证明,PAT和FMT都能够检测小鼠腹膜腔深处的卵巢肿瘤。靶向的纳米探针可以通过PAT通过高分辨率对肿瘤进行定位,并通过FMT以高灵敏度和特异性对肿瘤进行定位。这项研究证明了HER-2 / neu靶向PAT / FMT方法在卵巢癌非侵入性或术中成像中的应用潜力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号